Developer docs
API playgroundTry for free, no card

Search company profiles

Accelera Pharma

Full company profile

uuid002iddl

Namestring
Accelera Pharma
Websiteurl
apcipharma.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Accelera Pharma is a privately held Canadian pharmaceutical distribution company headquartered in Mississauga, Ontario, founded in 2018. Per the firmographic profile, the company specializes in pharmaceutical distribution with a focus on dermatology products and secure online transactions, suggesting a niche specialty-distribution positioning rather than broad-line wholesale.

The company's stated scope is 11–50 employees, placing it in the small-business tier relative to the broader Canadian pharmaceutical distribution sector. The website (apcipharma.com) currently displays only a verification/loading placeholder rather than substantive company content, and no management team, product catalog, technology stack, certifications, partnerships, or pricing information was resolvable from the input sources.

No funding rounds, M&A activity, geographic footprint, ownership structure, or revenue figures are disclosed. The "secure online transactions" descriptor implies some form of e-commerce or controlled-substance ordering infrastructure, but no first-party evidence of the underlying mechanics, customer segments served, or commercial channels is available. Commercial, operational, and technological visibility into the business is materially constrained by the absence of verifiable primary content.

Short descriptiontext

Accelera Pharma is a privately held Canadian pharmaceutical distribution company founded in 2018 and based in Mississauga, Ontario. With 11–50 employees, it focuses on dermatology products and secure online transactions within specialty pharma distribution.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMississauga, Canada
HQ citystring
Mississauga
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
pharmaceutical distribution, dermatology products, specialty pharmaceuticals, online pharmacy services, dermatological therapeutics
Industry3 codes
1Prescription Pharmaceutical (Rx) Wholesale Distribution
CodeCRAOAHAAPrimaryYes
2Dermatology & Aesthetics Pharmaceuticals
CodeHLAIAAAKPrimaryNo
3Health, Wellness & Pharmacy Marketplaces
CodeCRAFABAFPrimaryNo
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Specialty Pharmaceutical Distribution
Social media profiles1 record
Cost components3 values
Supply Chain, Operations, Personnel
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Accelera Pharma distributes pharmaceutical products with a focus on dermatology, conducting business through secure online transactions. The company operates as a specialty pharmaceutical distributor serving the dermatology therapeutic area.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Dermatology Pharmaceutical Distribution
No data
Peers10 records
TypeBroad incumbent
Description

Cardinal Health is a major US-headquartered pharmaceutical distributor and healthcare services company with global operations. Comparable as one of the largest pharmaceutical wholesalers whose scale economies and contracting power set the benchmark any smaller specialty distributor must work against.

TypeDirect peer
Description

Galderma is the world's largest independent dermatology-focused pharmaceutical company, offering prescription and aesthetic dermatology products. Comparable as a dermatology specialty pharma whose Canadian distribution channel partner profile Accelera would either align with or compete against for dermatology prescribing relationships.

TypeRegional player
Description

Shoppers Drug Mart is Canada's largest retail pharmacy chain, dispensing prescription drugs and selling pharmacy/health merchandise nationally. Comparable as a major Canadian pharmacy and drug retail channel that a Canadian pharmaceutical distribution specialist would interact with as both a customer and an adjacent competitor.

TypeBroad incumbent
Description

Cencora (formerly AmerisourceBergen) is a global pharmaceutical distributor and solutions provider serving manufacturers, pharmacies, and providers. As one of the Big Three North American pharma wholesalers, it represents the broad incumbent benchmark on distribution scale, dermatology line coverage, and manufacturer relationships.

TypeRegional player
Description

Apotex is Canada's largest generic pharmaceutical manufacturer, headquartered in the Toronto/Mississauga area. Comparable as a Canadian pharma company operating in the same therapeutic categories including dermatology generics, providing both a potential upstream supplier and adjacent benchmark for category depth.

TypeBroad incumbent
Description

McKesson is one of Canada's largest pharmaceutical wholesalers, distributing prescription drugs and health products across retail pharmacies, hospitals, and clinics. It is the dominant incumbent in Canadian pharma distribution that any specialist distributor like Accelera would compete against on supplier access and logistics scale.

TypeDirect peer
Description

Kohl & Frisch is a Canadian-owned pharmaceutical distributor serving retail pharmacies across Canada. Comparable as a domestic Canadian pharma wholesaler of similar smaller-mid scale competing for retail pharmacy contracts in the same market geography as Accelera.

TypeDirect peer
Description

Bausch Health is a global specialty pharmaceutical company with a strong dermatology franchise (Bausch + Lomb skincare, prescription derms). Comparable as a vertically adjacent specialty pharma participant whose dermatology product portfolio a Canadian dermatology-focused distributor would handle or compete against in formulary access.

TypeEmerging player
Description

PharmaDerm is the branded dermatology prescription division of Bausch Health focused on acne, psoriasis, and atopic dermatitis. Comparable as a dermatology-specialty pharma channel participant whose product set overlaps directly with what Accelera would distribute.

TypeRegional player
Description

Lupin Pharmaceuticals operates in Canada distributing dermatology and specialty generics. Comparable as an international specialty/generic pharma with a Canadian dermatology footprint that could share distribution channels with Accelera or compete for similar dermatology accounts.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Accelera Pharma

Specialty Pharmaceutical Distributionapcipharma.com

Accelera Pharma is a privately held Canadian pharmaceutical distribution company founded in 2018 and based in Mississauga, Ontario. With 11–50 employees, it focuses on dermatology products and secure online transactions within specialty pharma distribution.

What Accelera Pharma does

Accelera Pharma is a privately held Canadian pharmaceutical distribution company headquartered in Mississauga, Ontario, founded in 2018. Per the firmographic profile, the company specializes in pharmaceutical distribution with a focus on dermatology products and secure online transactions, suggesting a niche specialty-distribution positioning rather than broad-line wholesale.

The company's stated scope is 11–50 employees, placing it in the small-business tier relative to the broader Canadian pharmaceutical distribution sector. The website (apcipharma.com) currently displays only a verification/loading placeholder rather than substantive company content, and no management team, product catalog, technology stack, certifications, partnerships, or pricing information was resolvable from the input sources.

No funding rounds, M&A activity, geographic footprint, ownership structure, or revenue figures are disclosed. The "secure online transactions" descriptor implies some form of e-commerce or controlled-substance ordering infrastructure, but no first-party evidence of the underlying mechanics, customer segments served, or commercial channels is available. Commercial, operational, and technological visibility into the business is materially constrained by the absence of verifiable primary content.

Accelera Pharma firmographics

Firmographics
Name
Accelera Pharma
Website
https://apcipharma.com
Company type
Private
Founded year
2018
Headcount range
11–50 employees
Short description
Accelera Pharma is a privately held Canadian pharmaceutical distribution company founded in 2018 and based in Mississauga, Ontario. With 11–50 employees, it focuses on dermatology products and secure online transactions within specialty pharma distribution.
Ownership category
akta.pro rank

Accelera Pharma industry classification

Industry
Product category
Specialty Pharmaceutical Distribution
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)
akta.pro secondary industries
Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Health, Wellness & Pharmacy Marketplaces (CRAFABAF)

Keywords

  • Pharmaceutical distribution
  • Dermatology products
  • Specialty pharmaceuticals
  • Online pharmacy services
  • Dermatological therapeutics

Where Accelera Pharma is headquartered

Location

Headquarters

HQ city
Mississauga
HQ country
Canada
HQ region
North America

Markets served

Accelera Pharma business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Operations, Personnel

Accelera Pharma product offering

Product offering

Core offering

Accelera Pharma distributes pharmaceutical products with a focus on dermatology, conducting business through secure online transactions. The company operates as a specialty pharmaceutical distributor serving the dermatology therapeutic area.

Differentiator

Problem solved

Functional benefit

Products and services

  • Dermatology Pharmaceutical Distribution

Companies that use Accelera Pharma

Customer profile

Ideal customer profiles1 record

Accelera Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Accelera Pharma competitors and assessment

Company assessment

Broad incumbents

  • Cardinal Health: Cardinal Health is a major US-headquartered pharmaceutical distributor and healthcare services company with global operations. Comparable as one of the largest pharmaceutical wholesalers whose scale economies and contracting power set the benchmark any smaller specialty distributor must work against.
  • AmerisourceBergen (now Cencora): Cencora (formerly AmerisourceBergen) is a global pharmaceutical distributor and solutions provider serving manufacturers, pharmacies, and providers. As one of the Big Three North American pharma wholesalers, it represents the broad incumbent benchmark on distribution scale, dermatology line coverage, and manufacturer relationships.
  • McKesson Canada: McKesson is one of Canada's largest pharmaceutical wholesalers, distributing prescription drugs and health products across retail pharmacies, hospitals, and clinics. It is the dominant incumbent in Canadian pharma distribution that any specialist distributor like Accelera would compete against on supplier access and logistics scale.

Direct peers

  • Galderma: Galderma is the world's largest independent dermatology-focused pharmaceutical company, offering prescription and aesthetic dermatology products. Comparable as a dermatology specialty pharma whose Canadian distribution channel partner profile Accelera would either align with or compete against for dermatology prescribing relationships.
  • Kohl & Frisch: Kohl & Frisch is a Canadian-owned pharmaceutical distributor serving retail pharmacies across Canada. Comparable as a domestic Canadian pharma wholesaler of similar smaller-mid scale competing for retail pharmacy contracts in the same market geography as Accelera.
  • Bausch Health: Bausch Health is a global specialty pharmaceutical company with a strong dermatology franchise (Bausch + Lomb skincare, prescription derms). Comparable as a vertically adjacent specialty pharma participant whose dermatology product portfolio a Canadian dermatology-focused distributor would handle or compete against in formulary access.

Regional players

  • Shoppers Drug Mart (Loblaw): Shoppers Drug Mart is Canada's largest retail pharmacy chain, dispensing prescription drugs and selling pharmacy/health merchandise nationally. Comparable as a major Canadian pharmacy and drug retail channel that a Canadian pharmaceutical distribution specialist would interact with as both a customer and an adjacent competitor.
  • Apotex: Apotex is Canada's largest generic pharmaceutical manufacturer, headquartered in the Toronto/Mississauga area. Comparable as a Canadian pharma company operating in the same therapeutic categories including dermatology generics, providing both a potential upstream supplier and adjacent benchmark for category depth.
  • Lupin Pharmaceuticals Canada: Lupin Pharmaceuticals operates in Canada distributing dermatology and specialty generics. Comparable as an international specialty/generic pharma with a Canadian dermatology footprint that could share distribution channels with Accelera or compete for similar dermatology accounts.

Emerging players

  • PharmaDerm (a division of Valeant/Bausch): PharmaDerm is the branded dermatology prescription division of Bausch Health focused on acne, psoriasis, and atopic dermatitis. Comparable as a dermatology-specialty pharma channel participant whose product set overlaps directly with what Accelera would distribute.

Market position

Strengths3 records

Weaknesses4 records

Key risks5 records

Key highlights4 records

Customer concentration

Accelera Pharma social profiles

Digital presence

Accelera Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Accelera Pharma leadership team

Management profile

Number of profiles

Accelera Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Accelera Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Accelera Pharma

What does Accelera Pharma do?

Accelera Pharma distributes pharmaceutical products with a focus on dermatology, conducting business through secure online transactions. The company operates as a specialty pharmaceutical distributor serving the dermatology therapeutic area.

When was Accelera Pharma founded?

Accelera Pharma was founded in 2018. It employs 11 to 50 people.

Where is Accelera Pharma based?

Accelera Pharma is headquartered in Mississauga, Canada, in the North America region.

Who are Accelera Pharma's main competitors?

Broad incumbents on record are Cardinal Health, AmerisourceBergen (now Cencora) and McKesson Canada. Direct peers are Galderma, Kohl & Frisch and Bausch Health. Regional players are Shoppers Drug Mart (Loblaw), Apotex and Lupin Pharmaceuticals Canada. PharmaDerm (a division of Valeant/Bausch) is listed as an emerging player.

Does Accelera Pharma have an API?

No public API is recorded for Accelera Pharma.

What industry is Accelera Pharma in?

Accelera Pharma's product category is Specialty Pharmaceutical Distribution. Its primary akta.pro industry code is CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 42421 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales